STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

被引：40

作者：

Lobello, Cosimo ^{[1
]}

Tichy, Boris ^{[1
]}

Bystry, Vojtech ^{[1
]}

Radova, Lenka ^{[1
]}

Filip, Daniel ^{[1
,2
,3
]}

Mraz, Marek ^{[1
,2
,3
]}

Montes-Mojarro, Ivonne-Aidee ^{[4
,5
]}

Prokoph, Nina ^{[6
]}

Larose, Hugo ^{[6
]}

Liang, Huan-Chang ^{[7
]}

Sharma, Geeta G. ^{[8
]}

Mologni, Luca ^{[8
]}

Belada, David ^{[9
,10
]}

Kamaradova, Katerina ^{[10
,11
]}

Fend, Falko ^{[4
,5
]}

Gambacorti-Passerini, Carlo ^{[8
]}

Merkel, Olaf ^{[7
]}

Turner, Suzanne D. ^{[1
,6
]}

Janikova, Andrea ^{[2
,3
]}

Pospisilova, Sarka ^{[1
,2
,3
]}

机构：

[1] Masaryk Univ, Cent European Inst Technol CEITEC, Ctr Mol Med, Brno, Czech Republic

[2] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic

[3] Med Fac MU, Brno, Czech Republic

[4] Eberhard Karls Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany

[5] Eberhard Karls Univ Tubingen, Comprehens Canc Ctr Tubingen, Tubingen, Germany

[6] Univ Cambridge, Dept Pathol, Div Cellular & Mol Pathol, Cambridge, England

[7] Med Univ Vienna, Dept Pathol, Vienna, Austria

[8] Univ Milano Bicocca, Dept Med & Surg, Monza, Italy

[9] Charles Univ Hosp, Dept Internal Med Hematol 4, Hradec Kralove, Czech Republic

[10] Fac Med, Hradec Kralove, Czech Republic

[11] Charles Univ Hosp, Fingerland Dept Pathol, Hradec Kralove, Czech Republic

来源：

LEUKEMIA | 2021年 / 35卷 / 05期

基金：

欧盟地平线“2020”;

关键词：

ALCL;

D O I：

10.1038/s41375-020-01093-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1500 / 1505

页数：6

共 50 条

[1] STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Cosimo Lobello
Boris Tichy
Vojtech Bystry
Lenka Radova
Daniel Filip
Marek Mraz
Ivonne-Aidee Montes-Mojarro
Nina Prokoph
Hugo Larose
Huan-Chang Liang
Geeta G. Sharma
Luca Mologni
David Belada
Katerina Kamaradova
Falko Fend
Carlo Gambacorti-Passerini
Olaf Merkel
Suzanne D. Turner
Andrea Janikova
Sarka Pospisilova
Leukemia, 2021, 35 : 1500 - 1505
[2] Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Crescenzo, Ramona
Abate, Francesco
Lasorsa, Elena
Tabbo', Fabrizio
Gaudiano, Marcello
Chiesa, Nicoletta
Di Giacomo, Filomena
Spaccarotella, Elisa
Barbarossa, Luigi
Ercole, Elisabetta
Todaro, Maria
Boi, Michela
Acquaviva, Andrea
Ficarra, Elisa
Novero, Domenico
Rinaldi, Andrea
Tousseyn, Thomas
Rosenwald, Andreas
Kenner, Lukas
Cerroni, Lorenzo
Tzankov, Alexander
Ponzoni, Maurilio
Paulli, Marco
Weisenburger, Dennis
Chan, Wing C.
Iqbal, Javeed
Piris, Miguel A.
Zamo', Alberto
Ciardullo, Carmela
Rossi, Davide
Gaidano, Gianluca
Pileri, Stefano
Tiacci, Enrico
Falini, Brunangelo
Shultz, Leonard D.
Mevellec, Laurence
Vialard, Jorge E.
Piva, Roberto
Bertoni, Francesco
Rabadan, Raul
Inghirami, Giorgio
CANCER CELL, 2015, 27 (04) : 516 - 532
[3] Pathogenic TP53 mutations Are Associated with a Poor Prognosis in De Novo AML
Lamble, Adam J.
Ries, Rhonda E.
Dang, Alice
Alonzo, Todd A.
Chisholm, Karen
Kolekar, Pandurang
Liu, Yanling
Tran, Quang
Cooper, Todd M.
Aplenc, Richard
Gamis, Alan S.
Kolb, Edward A.
Ma, Xiaotu
Meshinchi, Soheil
BLOOD, 2022, 140 : 6297 - 6298
[4] The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis
Qiu, Lianqun
Medeiros, L. Jeffrey
Tang, Guilin
Khanlari, Mahsa
Li, Shaoying
Konoplev, Sergej
Wang, Sa A.
Yin, C. Cameron
Khoury, Joseph D.
Wang, Wei
Miranda, Roberto N.
Iyer, Swaminathan
You, M. James
Xu, Jie
CANCERS, 2021, 13 (24)
[5] Prognostic significance of STAT3 activation in systemic anaplastic large cell lymphoma
Khoury, JD
Medeiros, LJ
Rassidakis, GZ
Tsioli, P
Leventaki, V
Schmitt-Graeff, A
Herling, M
Sarris, AH
Lai, R
LABORATORY INVESTIGATION, 2003, 83 (01) : 239A - 240A
[6] Prognostic significance of STAT3 activation in systemic anaplastic large cell lymphoma
Khoury, JD
Medeiros, LJ
Rassidakis, GZ
Tsioli, P
Leventaki, V
Schmitt-Graeff, A
Herling, M
Sarris, AH
Lai, R
MODERN PATHOLOGY, 2003, 16 (01) : 239A - 240A
[7] Convergent Mutations and New Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Crescenzo, Ramona
Abate, Francesco
Lasorsa, Elena
Tabbo', Fabrizio
Gaudiano, Marcello
Chiesa, Nicoletta
Di Giacomo, Filomena
Spaccarotella, Elisa
Barbarossa, Luigi
Todaro, Maria
Boi, Michela
Tousseyn, Thomas
Rosenwald, Andreas
Kenner, Lukas
Rossi, Davide
Mevellec, Laurence
Vialard, Jorge
Bertoni, Francesco
Rabadan, Raul
Inghirami, Giorgio
BLOOD, 2014, 124 (21)
[8] Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A
Di Napoli, Arianna
Jain, Preti
Duranti, Enrico
Margolskee, Elizabeth
Arancio, Walter
Facchetti, Fabio
Alobeid, Bachir
di Pompeo, Fabio Santanelli
Mansukhani, Mahesh
Bhagat, Govind
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (05) : 741 - 744
[9] Prognosis and Efficacy Analysis of Diffuse Large B-Cell Lymphoma with TP53 Mutations: A Single-Center Study
Zhang, Haiyan
Zhang, Xiang
Wang, Jinghan
Zhang, Xuewu
Lv, Yunfei
Zhu, Yanan
Wei, Juying
Yang, Min
Xu, Gaixiang
Ye, Xingnong
Lou, Yinjun
Yang, Chunmei
Meng, Haitao
Xie, Wanzhuo
Tong, Hongyan
Yu, Wenjuan
BLOOD, 2024, 144 : 6468 - 6469
[10] Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
Blombery, Piers
Thompson, Ella R.
Jones, Kate
Arnau, Gisela Mir
Lade, Stephen
Markham, John F.
Li, Jason
Deva, Anand
Johnstone, Ricky W.
Khot, Amit
Prince, H. Miles
Westerman, David
HAEMATOLOGICA, 2016, 101 (09)

← 1 2 3 4 5 →